Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis-Multivariable Prediction Model Based on Machine Learning.
Queiro R, Seoane-Mato D, Laiz A, Galindez Agirregoikoa E, Montilla C, Park HS, Tasende JAP, Baute JJB, Joven Ibáñez B, Toniolo E, Ramírez J, Montero N, Pruenza García-Hinojosa C, Serrano García A, On Behalf Of The Proyecto Reapser Study. Queiro R, et al. Among authors: joven ibanez b. J Clin Med. 2023 Jan 25;12(3):931. doi: 10.3390/jcm12030931. J Clin Med. 2023. PMID: 36769579 Free PMC article.
Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology.
Queiro R, Laiz A, Seoane-Mato D, Galindez Agirregoikoa E, Montilla C, Park HS, Bethencourt Baute JJ, Bustabad S, Pinto Tasende JA, Tejón P, Joven Ibáñez B, Ramírez J, Cuervo A, Cañete JD, Trenor Larraz P, Ordás C, Alonso S, García-Fernández E, Toniolo E, Moreno Ramos MJ, Beteta MD, Lojo Oliveira L, Navío Marco T, Cebrián L, Barbazán C, Maceiras F, Rodriguez-Moreno J, Steiner M, Muñoz-Fernández S, Nóvoa Medina FJ, León M, Rubio E, Medina Luezas J, Sánchez-González MD, Arévalo M, Gratacós J, Senabre JM, Rosas JC, Santos Soler G, Nieto-González JC, González C, López Robles A, Álvarez Castro C, Ruiz Montesino MD, Torrente-Segarra V, Fernández-Carballido C, Martínez-Vidal MP, Jovani V, Urruticoechea-Arana A, Cabello Fernández Y, Toledo MD, Almodóvar R, Belmonte-Serrano MÁ, Notario Ferreira I, Raya Álvarez E; Grupo de Trabajo del Proyecto REAPSER. Queiro R, et al. Among authors: joven ibanez b. Reumatol Clin (Engl Ed). 2019 Sep-Oct;15(5):252-257. doi: 10.1016/j.reuma.2018.09.008. Epub 2018 Dec 3. Reumatol Clin (Engl Ed). 2019. PMID: 30522944 Free article. English, Spanish.
Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning.
Queiro R, Seoane-Mato D, Laiz A, Galindez Agirregoikoa E, Montilla C, Park HS, Pinto Tasende JA, Bethencourt Baute JJ, Joven Ibáñez B, Toniolo E, Ramírez J, Pruenza García-Hinojosa C. Queiro R, et al. Among authors: joven ibanez b. Front Med (Lausanne). 2022 Apr 28;9:891863. doi: 10.3389/fmed.2022.891863. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572968 Free PMC article.
Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis.
Queiro R, Seoane-Mato D, Laiz A, Galíndez Agirregoikoa E, Montilla C, Park HS, Pinto-Tasende JA, Bethencourt Baute JJ, Joven Ibáñez B, Toniolo E, Ramírez J, González Marcos A; and the Proyecto REAPSER Study Group. Queiro R, et al. Among authors: joven ibanez b. Clin Exp Rheumatol. 2023 Jan;41(1):137-144. doi: 10.55563/clinexprheumatol/077ul6. Epub 2022 Jun 13. Clin Exp Rheumatol. 2023. PMID: 35699067
Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain.
Valero-Martínez C, Urgelles JF, Sallés M, Joven-Ibáñez BE, de Juanes A, Ramírez J, Juanola X, Almodóvar R, Laiz A, Moreno M, Pujol M, Beltrán E, Pinto-Tasende JA, Crespí L, Sala-Icardo L, Castañeda S, García-Vicuña R. Valero-Martínez C, et al. Among authors: joven ibanez be. Front Immunol. 2023 Oct 23;14:1283251. doi: 10.3389/fimmu.2023.1283251. eCollection 2023. Front Immunol. 2023. PMID: 37936691 Free PMC article.
Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data.
Van Kuijk AWR, Nurmohamed MT, Siebert S, Bergmans P, de Vlam K, Gremese E, Joven-Ibáñez B, Korotaeva TV, Lavie F, Sharaf M, Noël W, Theander E, Smolen JS, Gossec L, van der Horst-Bruinsma IE. Van Kuijk AWR, et al. Among authors: joven ibanez b. Rheumatology (Oxford). 2023 Oct 3;62(10):3382-3390. doi: 10.1093/rheumatology/kead089. Rheumatology (Oxford). 2023. PMID: 36810788 Free PMC article.
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study.
Gossec L, Siebert S, Bergmans P, de Vlam K, Gremese E, Joven-Ibáñez B, Korotaeva TV, Lavie F, Noël W, Nurmohamed MT, Sfikakis PP, Sharaf M, Theander E, Smolen JS. Gossec L, et al. Among authors: joven ibanez b. Ann Rheum Dis. 2023 Apr;82(4):496-506. doi: 10.1136/ard-2022-222879. Epub 2022 Dec 13. Ann Rheum Dis. 2023. PMID: 36600178 Free PMC article.
Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study.
Gossec L, Siebert S, Bergmans P, de Vlam K, Gremese E, Joven-Ibáñez B, Korotaeva TV, Lavie F, Noël W, Nurmohamed MT, Sfikakis PP, Theander E, Smolen JS. Gossec L, et al. Among authors: joven ibanez b. Ann Rheum Dis. 2022 Jun;81(6):823-830. doi: 10.1136/annrheumdis-2021-221640. Epub 2022 Feb 24. Ann Rheum Dis. 2022. PMID: 35210262 Free PMC article.
Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results.
Smolen JS, Siebert S, Korotaeva TV, Selmi C, Bergmans P, Gremese E, Joven-Ibáñez B, Katsifis G, Noël W, Nurmohamed MT, Richette P, Sfikakis PP, de Vlam K, Theander E, Gossec L. Smolen JS, et al. Among authors: joven ibanez b. Ann Rheum Dis. 2021 Nov;80(11):1419-1428. doi: 10.1136/annrheumdis-2021-220263. Epub 2021 Jun 23. Ann Rheum Dis. 2021. PMID: 34162594 Free PMC article.
Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study.
Gossec L, Siebert S, Bergmans P, de Vlam K, Gremese E, Joven-Ibáñez B, Korotaeva TV, Lavie F, Noël W, Nurmohamed MT, Sfikakis PP, Sharaf M, Theander E, Smolen JS. Gossec L, et al. Among authors: joven ibanez b. Arthritis Res Ther. 2023 Jun 23;25(1):109. doi: 10.1186/s13075-023-03058-y. Arthritis Res Ther. 2023. PMID: 37353788 Free PMC article.
13 results